Dysphonia News and Research

RSS
MiRus announces FDA clearance of CYGNUS Anterior Cervical Plate System

MiRus announces FDA clearance of CYGNUS Anterior Cervical Plate System

Stress may cause vocal disorders

Stress may cause vocal disorders

Study explores impact of voice disorders ad listener strategies on speech intelligibility

Study explores impact of voice disorders ad listener strategies on speech intelligibility

FDA approves first generic version of commonly prescribed asthma inhaler

FDA approves first generic version of commonly prescribed asthma inhaler

MUSC researchers uncover a new cause for laryngeal symptoms

MUSC researchers uncover a new cause for laryngeal symptoms

FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma

FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma

FDA approves new drug for treatment of lung disease caused by Mycobacterium avium complex

FDA approves new drug for treatment of lung disease caused by Mycobacterium avium complex

Stivarga receives expanded FDA approval for treatment of liver cancer

Stivarga receives expanded FDA approval for treatment of liver cancer

Bayer-new phase 3 liver cancer data

Bayer-new phase 3 liver cancer data

Cerebellar not cerebral atrophy predicts poor anti-NMDAR encephalitis outcome

Cerebellar not cerebral atrophy predicts poor anti-NMDAR encephalitis outcome

FDA accepts Allergan's resubmission of BOTOX sBLA for treatment of adults with upper limb spasticity

FDA accepts Allergan's resubmission of BOTOX sBLA for treatment of adults with upper limb spasticity

Lenvatinib-everolimus combination extends PFS in patients with mRCC versus everolimus alone

Lenvatinib-everolimus combination extends PFS in patients with mRCC versus everolimus alone

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

Eisai announces FDA approval of LENVIMA (lenvatinib) for treatment of RAI-refractory DTC

New device to monitor voice professionals and track vocal changes

New device to monitor voice professionals and track vocal changes

Bayer enrolls patients for Phase III trial of Stivarga (regorafenib) tablets in colorectal cancer

Bayer enrolls patients for Phase III trial of Stivarga (regorafenib) tablets in colorectal cancer

Pfizer and Merck join forces to explore therapeutic potential of anti-PD-1 therapy

Pfizer and Merck join forces to explore therapeutic potential of anti-PD-1 therapy

Ipsen reports positive initial results from Dysport phase III study in Adult Upper Limb spasticity

Ipsen reports positive initial results from Dysport phase III study in Adult Upper Limb spasticity

European Commission approves Stivarga tablets for treatment of patients with mCRC

European Commission approves Stivarga tablets for treatment of patients with mCRC

Bayer HealthCare to present new data on oncology portfolio at ASCO meeting

Bayer HealthCare to present new data on oncology portfolio at ASCO meeting

Bayer HealthCare: Patient enrollment underway in Phase III trial of Stivarga tablets for treatment of HCC

Bayer HealthCare: Patient enrollment underway in Phase III trial of Stivarga tablets for treatment of HCC